Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections

In 2018, the Japanese medical reimbursement system was revised to introduce a fee for the implementation of an antimicrobial stewardship (AS) fee for pediatric patients. The purpose of this study was to evaluate physicians' prescription behavior following this revision. We conducted a retrospec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC health services research 2020-05, Vol.20 (1), p.399-399, Article 399
Hauptverfasser:	Muraki, Yuichi, Kusama, Yoshiki, Tanabe, Masaki, Hayakawa, Kayoko, Gu, Yoshiaki, Ishikane, Masahiro, Yamasaki, Daisuke, Yagi, Tetsuya, Ohmagari, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Age groups Anti-Bacterial Agents - therapeutic use Antibiotics Antimicrobial agents Antimicrobial resistance Antimicrobial Stewardship Child Child health Drug Prescriptions - economics Drug resistance Drug therapy Fees and Charges Female Health aspects Health facilities Health services Humans Infection Japan Legal fees Lung diseases Male Medical research Microbial drug resistance Outpatients Patients Pediatric pharmacology Pediatrics Practice Patterns, Physicians Prescription writing Prescriptions Respiratory Tract Infections - drug therapy Retrospective Studies Statistical significance Upper respiratory tract infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In 2018, the Japanese medical reimbursement system was revised to introduce a fee for the implementation of an antimicrobial stewardship (AS) fee for pediatric patients. The purpose of this study was to evaluate physicians' prescription behavior following this revision. We conducted a retrospective observational study from January 1, 2017 to September 30, 2018 of pediatric (
ISSN:	1472-6963 1472-6963
DOI:	10.1186/s12913-020-05288-1